An in-depth look to ALAR PHARMACEUTICALS INC operating, investing, and financing activities

6785 free cash flow for Q1 24 is 19.35 M TWD. For 2023, 6785 free cash flow was 411.25 M TWD and operating cash flow was 417.59 M TWD.